FdaApplication
ANDA 217466
Identifiers
- fda_app_no: ANDA217466
Properties
| Property | Value |
|---|---|
| applicant_name | ASPIRO PHARMA LTD |
| application_type | ANDA |
| approval_date | 2023-03-22 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| OLANZAPINE | OLANZAPINE | 10MG/VIAL | POWDER;INTRAMUSCULAR |
1 product